Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

20171,903 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 389, Issue 10073, pp. 1011-1024

Field-Weighted Citation Impact: 94.31